Actuate Therapeutics Inc (ACTU)

Finanzdaten der Actuate Therapeutics Inc-Aktie (ACTU)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	14.01%4.91	5.71	4.69	5.47	5.97
Research and Development	19.43%2.07	2.57	2.13	2.18	2.76
Operating Income/Loss	14.01%-4.91	-5.71	-4.69	-5.47	-5.97
Nonoperating Income/Loss	50.19%0.04	0.08	0.13	0.06	0.02
	13.49%-4.87	-5.63	-4.55	-5.41	-5.95
Attributable To Parent	13.49%-4.87	-5.63	-4.55	-5.41	-5.95
Basic Average Shares	1.42%23.87	23.54	-	21.39	19.65
Diluted Average Shares	1.42%23.87	23.54	-	21.39	19.65
Basic Earnings Per Share	16.67%-0.20	-0.24	-	-0.25	-0.30
Diluted Earnings Per Share	16.67%-0.20	-0.24	-	-0.25	-0.30